Merck announces approval of new cholesterol-lowering drug
Drugmaker Merck has received regulatory approval for a new medication aimed at lowering cholesterol. The drug offers an additional treatment option for patients with high cholesterol, a condition linked to heart disease and stroke. This development expands the range of therapies available to manage cardiovascular risk.